We only have this paper's title and publication details.
Read it at the sourceThis review compares pricing trends for semaglutide and tirzepatide in India, highlighting generics' impact on accessibility.
No takes yet. Share an insight, caveat, or question.
Saraf et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: